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1ABSTRACT
A novel siderophore system is essential for the growth of Pseudomonas 
aeruginosa in airway mucus
Mia Gi
Department of Medical Science
The Graduate School, Yonsei University
(Directed by Professor Jae Young Choi)
Pseudomonas aeruginosa establishes airway infections in Cystic 
Fibrosis patients. Here, we investigate the molecular interactions between P. 
aeruginosa and airway mucus secretions (AMS) derived from the primary 
cultures of normal human tracheal epithelial (NHTE) cells. PAO1, a 
prototype strain of P. aeruginosa, was capable of proliferating during 
incubation with AMS, while all other tested bacterial species perished. A 
PAO1 mutant lacking PA4834 gene became susceptible to AMS treatment. 
The ΔPA4834 mutant was grown in AMS supplemented with 100 μM ferric 
iron, suggesting that the PA4834 gene product is involved in iron metabolism. 
Consistently, intracellular iron content was decreased in the mutant, but not 
in PAO1 after the AMS treatment. Importantly, a PAO1 mutant unable to
produce both pyoverdine and pyochelin remained viable, suggesting that 
these two major siderophore molecules are dispensable for maintaining 
2viability during incubation with AMS. The ΔPA4834 mutant was regrown in 
AMS amended with 100 μM nicotianamine, a phytosiderophore whose 
production is predicted to be mediated by the PA4836 gene. Infectivity of the 
ΔPA4834 mutant was also significantly compromised in vivo. Together, our 
results identify a genetic element encoding a novel iron acquisition system 
that plays a previously undiscovered role in P. aeruginosa airway infection.
Key words: PA4834 gene, siderophore system, airway mucus secretion
3A novel siderophore system is essential for the growth of Pseudomonas 
aeruginosa in airway mucus
Mia Gi
Department of Medical Science
The Graduate School, Yonsei University
(Directed by Professor Jae Young Choi)
Ⅰ. INTRUDUCTION
Pseudomonas aeruginosa is a highly adaptable Gram-negative bacterium that
colonizes various environmental niches and causes major airway infections. Notably, 
60-70% of patients with cystic fibrosis (CF) are infected by P. aeruginosa in the 
airway as the disease progresses to the age of 20.1 As a major opportunistic pathogen, 
P. aeruginosa also infects patients suffering from ventilator-associated pneumonia2 or 
burn wounds.3 Previous studies demonstrated that thickened airway mucus caused by 
mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene 
may be less effective in eliminating microbial invaders4 due in part to decreased 
mucociliary clearance.5 The concentrations of major ions in the airway mucus have 
been precisely determined and were not significantly different between normal and 
CF samples,6 supporting the notion that isotonic volume changes in airway surface 
liquid accounts for defective mucociliary clearance followed by P. aeruginosa
infection in the CF airway.7 Furthermore, the abnormally altered CF airway was found 
to be anaerobic8 and P. aeruginosa was found to form robust biofilms during 
4anaerobiosis.9-11 However, these findings do not fully explain why P. aeruginosa has 
been exceptionally capable of establishing chronic airway infections. 
Airway mucus contains various antibacterial components such as lysozyme,12
lactoferrin12 and IgA,13 which suppress bacterial growth on the airway surface.
Notably, elevated lysozyme activity and lactoferrin levels were observed in the 
bronchoalveolar lavage fluid (BALF) derived from CF patients.14 In the same study, it 
was also shown that lysozyme and lactoferrin levels were increased in older CF 
patients.14 These data suggest that the degree of P. aeruginosa infection may not 
correlate with the levels of these molecules in the CF airway and frequent P. 
aeruginosa infection is likely ascribed to its ability to effectively respond to host-
specific hostile environments.
Iron is essential for bacterial survival and typical bacterial organisms require 
micromolar levels of iron for optimal growth.15,16 However, the utilization of iron is 
limited by the host as most iron is bound to circulating proteins such as transferrin, 
lactoferrin, and ferritin in vivo.17 To sequester iron for their own use, bacterial species
possess a myriad of mechanisms that regulate the expression, secretion, and 
internalization of iron chelating compounds termed siderophores. Bacterial iron 
metabolism has been extensively studied using P. aeruginosa as a model organism. 
Pyochelin and pyoverdine are well-characterized siderophore molecules that P. 
aeruginosa produces under iron-limited conditions.18 Siderophore-mediated processes 
also participate in virulence regulation of P. aeruginosa.19,20 Intriguingly, pyoverdine-
defective P. aeruginosa strains have been detected in CF sputa.21,22 Moreover, a PAO1 
mutant defective in both pyochelin and pyoverdine was found to colonize the lungs of 
immunocompromised mice, even though its virulence was attenuated.23 These results 
indicate that additional iron-acquisition mechanisms may play a more important role 
during airway infection. In support of this notion, diverse iron acquisition pathways 
5have been reported in P. aeruginosa, including heme uptake systems,24 TonB-
dependent uptake systems,25 and the FeOABC system.26  
Airway mucus is a frontline defense of the innate immune response against 
invading bacterial pathogens; however, physiological changes induced in P. 
aeruginosa during interactions with airway mucus are not clearly understood at the 
molecular genetic level. In this study, we investigated various bacterial responses to 
airway mucus secretions (AMS) harvested from primary cultures of normal human 
tracheal epithelial (NHTE) cells. Unlike other bacterial species of clinical significance, 
P. aeruginosa exhibited resistance to treatment with AMS and was capable of 
replicating in its presence as well. We took a genome-wide approach to uncover a 
genetic determinant responsible for a previously uncharacterized iron uptake 
mechanism. This report provides novel insight into the interaction between P. 
aeruginosa and the host, especially at the early stages of airway infection. In addition, 
this work proposes a drug target, the inhibition of which may contribute to the 
efficient eradication of this important pathogen.
6Ⅱ. MATERIALA AND METHODS
1. Experimental ethics
Experiments using human subjects and experimental animals were performed in 
strict accordance with guidelines provided by Yonsei University. Protocols were 
reviewed and approved by Institutional Review Board of Yonsei University College 
of Medicine. Permit numbers for primary culture of human tissues and mouse 
infection experiment were 2014-1842-001 and 2011-0173-2, respectively.
2. Bacterial strains, cell lines, and growth conditions
Bacterial strains and plasmids used in the current study are listed in the 
paragraph (Table 1). Luria-Bertani medium (LB; 10 g tryptone, 5 g yeast extract, and 
10 g NaCl per liter) was used to grow bacterial precultures. For bacterial incubation 
with AMS, LB-grown bacterial cells were washed with PBS and diluted 10,000-fold 
into 100 μl of AMS placed in the wells of 96-well plates. Bacterial cells were then 
grown for 16 hrs in a humidified 37 °C incubator. Bacterial growth was assessed by 
measuring the growth index. Unless otherwise noted, the values for log10 (CFUafter 16 hrs
in AMS or LB/CFUafter 16 hrs in PBS) were calculated and plotted as the growth index. NuLi-1 
(ATCC® CRL-4011™) and CuFi-1 (ATCC® CRL-4013™) cell lines were purchased 
from ATCC (Rockville, MA). Cell line maintenance and cultures were conducted 
following standard tissue culture techniques. Transposon insertion mutants of P. 
aeruginosa were purchased from a P. aeruginosa transposon mutant library 
(http://www.genome.washington.edu/UWGC/pseudomonas). The targeted gene 
mutations were introduced by allele replacement as previously described11.
7Table 1. Bacterial strains and plasmids used in this study
Strains or plasmids Relevant characteristics Ref. or source
P. aeruginosa strains
PAO1 Wild-type PAO1, ATCC Lab collection
ΔPA4834 PA01, PA4834 deleted This study
Δpvd PAO1, PA2396 and PA2397 deleted This study
Δpch PAO1, PA4224 and PA4225 deleted This study
ΔpvdΔpch
PAO1, PA2396, PA2397, PA4224 and PA4225 
deleted
This study
ΔPA4834Δpvd PA01, PA4834, PA2396 and PA2397 deleted This study
ΔPA4834Δpch PA01, PA4834, PA4224 and PA4225 deleted This study
ΔPA4834ΔpvdΔpch
PA01, PA4834, PA2396, PA2397, PA4224 and 
PA4225 deleted
This study
ΔPA4834::Tn PW9128, PA4834:: ISlacZ/hah, UW strain 27
ΔPA4834/pJN105 ΔPA4834, empty vector control This study
ΔPA4834/pJN105::PA4834 ΔPA4834 complementation strain This study
E. coli strains
SM10/λpir
Kmr thi-1 thr leu tonA lacY supE recA::RP4–2-
Tc::Mu pir+, for conjugal transfer
28
Other bacterial species
Staphylococcus aureus Lab collection
Bacillus cereus Lab collection
Escherichia coli DH5α Lab collection
Vibrio cholerae N16961 Lab collection
Salmonella enterica serovar
Typhimurium
LT2 Lab collection
Listeria monocytogenes Lab collection
Plasmids
pCVD442 sacB suicide vector from plasmid pUM24 28
pJN105
pJN105 araC-PBAD cassette cloned in 
pBBR1MCS-5, Gmr
29
pJN105::PA4834 pJN105 inducible vector with fragment of PA4834 This study
83. Preparation of airway mucus secretions (AMS)
AMS was collected from primary cultures of normal human tracheal epithelial 
(NHTE) cells following procedures described previously.30 In brief, a piece of human 
trachea was harvested from patients without airway disease during tracheotomy. 
Second passage NHTE cells (105 cells / culture) were seeded in 0.5 ml of culture 
medium onto 24.5 mm, 0.45 mm pore size TranswellÒ clear culture inserts (Costar 
Co., Cambridge, MA). Cultured cells were grown submerged, and the culture medium 
was changed on the first day and every other day thereafter. After cultures reached 
confluence, media on the luminal side was removed to create an air–liquid interface 
(ALI) to facilitate differentiation into ciliated columnar epithelial cells with polarity. 
To harvest AMS, we washed the apical surface of the NHTE cells with 1 ml PBS. All 
patients provided informed consent, and the Institutional Review Board of Yonsei 
University College of Medicine approved this study (2014-1842-001).
4. Complementation of the ΔPA4834 mutant
A 0.86-kb NdeI-HindIII fragment containing the entire PA4834 gene was 
amplified from the PAO1 genome and ligated into NdeI/HindIII-treated pET21b. To 
complement the ΔPA4834 mutant, the arabinose-inducible expression vector pJN10529
was used. PCR was used to amplify the PA4834 gene along with the ribosome binding 
site (RBS) that originated from pET21b. The EcoRI/XbaI-digested PCR product was 
ligated into EcoRI/XbaI-digested pJN105. The resulting plasmid and the control 
empty plasmid (i.e., pJN105) were transferred into the ΔPA4834 mutant by 
electroporation.
5. Microarray analysis
Genome-wide transcriptome analysis was performed using GeneChip P. 
aeruginosa genome arrays (Affymetrix, Santa Clara, CA). PBS-washed PAO1 cells 
9precultured in LB overnight were incubated for 6 hrs in PBS or in AMS. RNA 
extraction, labeling, hybridization, and data analysis were performed as described 
elsewhere.11
6. Antibiotic sensitivity assay
Commercially purchased filter discs (BBL Sensi-Disc susceptibility test discs; 
Becton, Dickinson and Company, Franklin Lakes, NJ) were used. After overnight 
incubation of PAO1, and ΔPA4834 mutant cells on LB agar plates containing various 
bacteria the zones of inhibition were measured.
7. Quantitative real time PCR
PA4834, PA4835, PA4836, and PA4837 gene transcript levels were determined by 
qRT-PCR, following previously described procedures11. Prior to RNA extraction, 
PAO1 cells were grown for 6 hrs in 1 mL of LB or AMS with shaking at 37°C. 
Transcript levels of the rpoD gene were also measured and used for normalizing 
PA4834, PA4835, PA4836, and PA4837 gene transcription. The primers used for qRT-
PCR are listed in Table 2.
Table 2. Primers used in this study
Gene name Direction Primer sequence (5'-3')a
Restricti
on sites
Mutant construction
PA4834 left Forward
ATATAGAGCTCGCCGAGCGCCAGGAATAC
CTG
SacI
PA4834 left Reverse
TAAATGGATCCCAGCAGGGTACCGATGGC
GC
BamHI
PA4834 right Forward
CCCTTGGATCCGGCATCGTCTTCAACGCC
GG
BamHI
PA4834 right Reverse
AAGGTGAGCTCACGCCTTTCTGCCTGGTC
ACG
SacI
10
pvd left Forward
ACACGGAGCTCCCCTTCCCGTTCGACGAA
GGTA
SacI
pvd left Reverse
CTTCCGGATCCTTCACCCGACGACACCAT
CCTC
BamHI
pvd right Forward
AGAGCGGATCCAATGCCTGGCTCGAAGA
GCGAC
BamHI
pvd right Reverse
CGATTGAGCTCACTCCTGGAGTGCGCTGC
CC
SacI
pch left Forward
ACACGGAGCTCAATGGCAAGGTCGATCGT
CGC
SacI
Pch left Reverse
CTTCCGGATCCCAGGTGTTCCAGCAGGGC
CTC
BamHI
pch right Forward
AGAGCGGATCCAACCAGCGCAGCCTGGA
GGT
BamHI
pch right Reverse
CGATTGAGCTCAGCGTGCGCGATCAGTTG
GT
SacI
complementation
PA4834
complementation
(cloning to 
pET21b)
Forward
CTTACCATATGGTGCTCGACCTGCTGAAG
AGC
NdeI
Reverse
AAATTAAGCTTGCCCTTCTTCGTCCGCGA
CAG
HindIII
PA4834
complementation
(cloning to 
pJN105)
Forward
ACTCTGAATTCAATAATTTTGTTTAACTTT
AAGAAGGAG
EcoRI
Reverse ATTGGTCTAGATCAGTGGTGGTGGTGGTG XbaI
Quantitative RT-PCR
PA4834
Forward GACCTGCTGAAGAGCGGGGT
Reverse GCTTCCTTGACCAGGGCGTT
PA4835
Forward TACGTGCACAGTCCGTTCTT
Reverse GATAGGTCCCTCCGGGTAGA
PA4836
Forward CTGTTCAACTATCCGGTGGAG
Reverse TTCTCCAGGATCAGGGTGTC
PA4837
Forward ACCTTGACAGCGCTCGTATC
Reverse AAGCCACGGACGTTGTACTC
rpoD (PA0576)
Forward AAGGCCCTGAAGAAGCACGG
Reverse GATCGGCATGAACAGCTCGG
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8. Scanning electron microscope
Primary cultured NHTE cells grown on permeable membrane (Costar Co., 
Cambridge, MA) were inoculated with overnight cultured PAO1, SA or ΔPA4834
mutant (2 × 104 CFU in 300 μl PBS). After 14 hrs incubation, the NHTE cells were 
fixed, dried and coated with platinum using a sputter coater (E1030; Hitachi).Coated 
specimens were then mounted on a stub holder and viewed using a cold-field 
emission scanning electron microscope (S-4300, Hitachi) operated at 15 kV.
9. Intracellular iron concentration
Inductively coupled plasma mass spectrometry (ICP-MS) was performed to 
determine the intracellular concentration of total iron. Bacterial pellets grown in LB 
or AMS were submitted to the Korea Basic Science Institute (Seoul, Korea), where 
subsequent procedures were performed. The cell-permeable green fluorescent heavy 
metal indicator, PhenGreen™ SK, diacetate (Molecular Probes, Inc., Eugene, OR) 
was used to fluorescently stain bacterial cells. Aliquots of bacterial suspensions were 
stained with 20 μM PhenGreen™ SK, diacetate for 30 min and fluorescent images 
were acquired using a fluorescent microscope (Zeiss LSM 700; Carl Zeiss Inc., 
Germany).
10. Iron sequestration assay
Bacterial strains were grown in LB and cell-free culture supernatants were 
subject to the iron sequestration assay using a colorimetric iron assay kit according to 
the manufacturer's instructions (SideroTech Kit. Emergen Bio Inc., Ireland). The 
assay is based on the color change that occurs as result of ferric iron transfer from the 
reagent complex to siderophore present in culture supernatants.
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11. Mouse infection
Methods for animal infection were approved by the Yonsei University College 
of Medicine Committee on the Ethics of Animal Experiments (permit number 2011-
0173-2). Effects of the PA4834 gene deletion on P. aeruginosa in vivo infectivity was 
monitored using two different mouse infection models, the thermally-injured mouse 
infection model31 and the acute airway infection32 model. For thermal injury, adult 
male C57BL/6 mice were anaesthetized and their backs were shaved. Thermal injury 
was induced by exposing the shaved skin (15% of their body surface) to an aluminum 
plate (16 mm diameter) heated to 99°C for 8 sec. Immediately after, sterilized gauze 
was fixed on the injured skin and the mice were then challenged by spraying 0.2 ml of 
2×108 P. aeruginosa CFU or 0.2 ml PBS (as the control) on the gauze. Acute airway 
infection was performed following the procedures described previously.32 For both 
infection experiments, affected tissues were recovered and stained with hematoxylin-
eosin for histological analysis.32
12. Statistical analysis.
Data are expressed as the mean ± standard deviation (SD). An unpaired Student’s 
t-test was used to analyze the data. A p value of < 0.05 was considered statistically 
significant. All the experiments were repeated for reproducibility. 
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Ⅲ. RESULTS
1. P. aeruginosa exhibits exceptional resistance in response to incubation with airway 
mucus secretions (AMS)
Airway mucus contains a variety of antimicrobial agents33 serving as a frontline 
immune defense against invading microorganisms. We first examined how AMS
exerts its effect on various bacterial species including human pathogens by comparing 
the number of viable cells before and after incubation with AMS. Bacterial growth 
was monitored by measuring the growth index as described in the Methods section. 
After 16 hrs incubation with AMS, all of the tested bacterial species, except for P. 
aeruginosa, lost their viability. S. aureus was the most susceptible to the treatment 
with AMS. In contrast, the growth index of PAO1, the prototype P. aeruginosa strain, 
was increased after the same treatment (Fig. 1A). 
Next, we measured bacterial growth in the presence of secretory products 
recovered from the culture of two different human airway epithelial cell lines, NuLi-1 
(normal airway epithelial cell line) and CuFi-1 (cystic fibrosis airway epithelial cell
line). The antibacterial activities of these secretions were found be weaker than the 
AMS prepared from the primary cultures of NHTE cells, and both secretions only 
partially inhibited S. aureus growth (Fig. 1B). No significant difference was observed 
between the two secretions in inhibiting the growth of S. aureus. Likewise, PAO1 
growth was not affected at all by incubation with each of the two secretions, further 
suggesting that PAO1 can develop full resistance to the secretions of NuLi-1 or CuFi-
1 cells (Fig. 1B). Together, these results demonstrate that P. aeruginosa both resists
the antimicrobial activity of AMS and also propagates during incubation with AMS. 
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Figure 1. Robust ability of P. aeruginosa to grow in airway mucus. (A) Seven 
different bacterial strains (SA, Staphylococcus aureus; BC, Bacillus cereus; EC, 
Escherichia coli; VC, Vibrio cholerae; ST, Salmonella enterica serovar Typhimurium; 
LM, Listeria monocytogenes; and PAO1, P. aeruginosa) were incubated with AMS 
prepared from primary cultures of normal human tracheal epithelial cells for 16 hrs. 
Changes in bacterial cell viability were monitored by calculating the growth index as 
described in the Materials and Methods. Four independent experiments were 
performed, and the mean values ± SD (error bars) are displayed in each bar. (B) P. 
aeruginosa strain PAO1 (PA) and S. aureus (SA) cells were incubated with secretions 
collected from cultured NuLi-1 (gray bars) and CuFi-1 (black bars) cells. Bacterial 
growth in LB media was also measured (white bars) and compared with other growth. 
Four independent experiments were performed, and the mean values ± SD (error bars) 
are displayed in each bar. *p < 0.05 vs. SA growth in LB media.
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2. Genome-wide expression analysis followed by mutant screening identified a PAO1 
mutant susceptible to AMS treatment
Our results show that PAO1 is exclusively resistant to the antimicrobial action of
AMS, which P. aeruginosa cells likely encounter during the early stages of the airway 
infection. To offer clues into the molecular basis of this unique resistance, we 
performed a microarray analysis. Table 3 shows a list of the top 35 genes that were 
most upregulated during incubation with AMS vs. PBS. Exposure to AMS influenced 
bacterial transcription dramatically, as evidenced by the extent to which expression 
was changed (~7- to ~56-fold increase). A substantial number of genes (16 genes) 
were determined to encode hypothetical proteins. Of note, four genes (pchB, pchG, 
pchE, and pchF) involved in the biosynthesis of pyochelin, a siderophore molecule 
for iron acquisition,34 were included in the list. Furthermore, expression of the pvdS
gene encoding a sigma factor that activates the production of pyoverdine, another iron 
chelator,35 was also highly induced in PAO1 cells grown in the presence of AMS.
Transcript levels of two genes (PA4834 and PA4837) constituting an operon were also
highly induced in response to AMS treatment (Table 3).
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Table 3. List of genes that are most upregulated during growth with AMS
PA 
number
Gene
Fold 
change a
Target Description
PA3446 56.63 conserved hypothetical protein
PA3600 49.03
conserved hypothetical protein /Translation, post-translational 
modification
PA0284 36.28 hypothetical protein
PA4063 35.15 hypothetical protein
PA3601 24.27
conserved hypothetical protein /Translation, post-translational 
modification
PA2359 21.93 probable transcriptional regulator
PA3450 21.63 probable antioxidant protein /adaptation, protection
PA4570 19.36 hypothetical protein
PA4471 18.45 hypothetical protein
PA2161 16.99 hypothetical protein
PA0802 16.82 hypothetical protein /Membrane proteins
PA5536 dksA2 15.69 DnaK suppressor protein
PA2062 15.52
probable pyridoxal-phosphate dependent enzyme /Putative 
enzymes
PA1911 femR 13.79 sigma factor regulator
PA2033 11.83 hypothetical protein
PA1905 phzG2 11.29 probable pyridoxamine 5'-phosphate oxidase /Secreted Factors
PA4230 pchB 10.98
salicylate biosynthesis protein PchB /Transport of small 
molecules; Secreted Factors
PA1373 fabF2 10.86
3-oxoacyl-acyl carrier protein synthase II /Fatty acid and 
phospholipid metabolism
PA4103 10.61 hypothetical protein
PA4224 pchG 10.61 pyochelin biosynthetic protein PchG
PA2570 lecA 10.15
PA-I galactophilic lectin /Adaptation, protection; Motility & 
Attachment Cell wall
PA2786 9.98 hypothetical protein
PA1300 9.66
probable sigma-70 factor, ECF subfamily /Transcriptional 
regulators
PA3381 9.55 probable transcriptional regulator /Transcriptional regulators
PA0993 cupC2 9.36
chaperone CupC2/probable pili assembly chaperone /Motility 
& Attachment
PA4033 mucE 9.01 hypothetical protein
17
PA4837 8.95 probable outer membrane protein precursor/Membrane proteins
PA4516 8.93 hypothetical protein
PA4834 8.33 hypothetical protein /Membrane proteins
PA4226 pchE 8.27
dihydroaeruginoic acid synthetase /Transport of small 
molecules; Secreted Factors
PA0790 8.05 hypothetical protein /Membrane proteins
PA3126 ibpA 7.92 heat-shock protein LbpA /Chaperones & heat shock proteins
PA1312 7.84 probable transcriptional regulator /Transcriptional regulators
PA2426 pvdS 7.76 sigma factor PvdS /Transcriptional regulators
PA4225 pchF 7.23
pyochelin synthetase /Transport of small molecules; Secreted 
Factors
a Fold change was based on expression level in PAO1 incubated in PBS for the same 
period of time. 
Next, we assessed the effect of disruption of each gene on the susceptibility of 
PAO1 to AMS treatment. Transposon (Tn) insertion mutants were grown in AMS and 
the growth index of each mutant was calculated (Table 4). All of the mutants grew 
fine in LB media (data not shown). While the 31 tested mutants exhibited varying 
degrees of growth, most of them showed positive growth index values (Table 4). Of 
importance is that mutations in either PA4063 or PA4834 resulted in growth inhibition 
in our initial screen (growth index < 0). Subsequent experiments indicated that the 
PA4834 Tn mutant was consistently susceptible to treatment with AMS. To further 
validate this result, we constructed an in-frame deletion mutant of PA4834 and the 
mutant also lost its viability when treated with AMS (growth index of approximately -
1.0), although the degree of viability loss was not as significant as what was observed 
in the S. aureus strain (Fig. 2A). Importantly, restored ability to grow in AMS was 
observed when the mutant was complemented with a plasmid-born wild-type copy of 
the PA4834 gene (Fig. 2A). For the investigation of bacterial colonization in NHTE 
cells, primary NHTE cells were differentiated at an air–liquid interface (ALI) for 8 
days. PAO1, SA and ΔPA4834 mutant were inoculated into the apical region of the 
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NHTE cells and incubated for 14 hrs. Fig. 2B represents scanning electron 
microscope (SEM) images of infected NHTE cells with seeded bacterial cells. PAO1 
invaded the NHTE cells and expanded (Fig. 2B). However SA and ΔPA4834 mutant
fewer in numbers and did not affect the NHTE cells (Fig. 2B). PA4834 is a component 
of four-gene operon (PA4834-PA4837). Each gene of the operon was evaluated for its 
expression. Quantitative RT-PCR analysis showed that PAO1 have 11, 10, 9, 19-fold 
increased levels of PA4834, PA4835, PA4836, and PA4837 gene transcripts, 
respectively, when grown in AMS compared to LB. This result suggests that the 
PA4834-PA4837 may be operon, and PA4834 plays an important role in the interaction 
with AMS (Fig. 2C).
Table 4. Effects of the disruption of upregulated genes on sensitivity to AMS 
treatment
Strains Growth index Strains Growth index
PAO1 2.46 (±0.61) PA1373::Tn 1.48
PA3446::Tn 2.23 PA4103::Tn 1.75
PA3600::Tn 1.71 PA4224::Tn 1.16
PA0284::Tn 1.77 PA2570::Tn 1.34
PA4063::Tn -0.06 PA2786::Tn not tested
PA3601::Tn 1.92 PA1300::Tn 1.45
PA2359::Tn 1.54 PA3381::Tn 1.03
PA3450::Tn not tested PA0993::Tn 1.45
PA4570::Tn 1.58 PA4033::Tn 2.20
PA4471::Tn 1.18 PA4837::Tn 1.93
PA2161::Tn 1.54 PA4516::Tn 1.90
PA0802::Tn 1.85 PA4834::Tn -0.18
PA5536::Tn 2.31 PA4226::Tn 2.94
PA2062::Tn 1.54 PA0790::Tn 2.34
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PA1911::Tn 1.32 PA3126::Tn 3.56
PA2033::Tn not tested PA1312::Tn 3.79
PA1905::Tn 1.53 PA2426::Tn 3.50
PA4230::Tn not tested PA4225::Tn 4.00
PA4834 is a component of a four-gene operon (PA4834-PA4837) and is predicted 
to encode a membrane-associated protein (www.pseudomonas.com). The PA4836 and 
PA4837 genes encode proteins homologous to nicotianamine synthase and a TonB-
dependent siderophore receptor, respectively (Table 5). Table 5 shows a list of 
bacterial species that were found to possess genes homologous to each component of 
the operon. P. aeruginosa strains contain all four genes, each with >99% sequence 
identity to the corresponding gene in PAO1. Sequence identities between cognate 
genes in PAO1 vs. PA7 were somewhat lower (91~96 %) at the nucleotide level 
(Table 5). Serratia sp. FS14 was found to harbor two genes similar to PA4834 and 
PA4835, with higher identity to the PA4834 gene. It is of interest that these two genes 
also constitute a likely six-gene operon, predicted to be involved in iron metabolism 
(data not shown). Other genomes on the list contain only one gene homologous to a 
corresponding gene of the PA4834-PA4837 operon (Table 5). Of note, the bacterial 
species tested in Fig. 1A were determined not to possess genetic elements similar to 
any part of the PA4834-PA4837 operon. Together, these results suggest that the 
PA4834-PA4837 operon is exclusively found in P. aeruginosa, and not in other 
bacterial species with sequenced genomes.
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Table 5. BLASTN search of PA4834, PA4835, PA4836 and PA4837 gene sequences
Genes PA4834 PA4835 PA4836 PA4837
Predicted function
EamA-like 
transporter family 
protein
Conserved 
uncharacterized
Nicotianamine 
synthase
TonB-dependent 
siderophore 
receptor
Bacterial species that contain genes homologous to PA4834, PA4835, PA4836 or PA4837
P. aeruginosa PA01
855 / 855
(100%)
1302 / 1302 
(100%)
792 / 792 
(100%)
2127 / 2127 
(100%)
P. aeruginosa DK2
855 / 855
(100%)
1296 / 1302 
(99%)
787 / 792
(99%)
2123 / 2127 
(99%)
P. aeruginosa LESB58
853 / 855
(99%)
1295 / 1302 
(99%)
784 / 792
(99%)
2114 / 212
7 (99%)
P. aeruginosa M18
853 / 855 
(99%)
1296 / 1302 
(99%)
786 / 792 
(99%)
2120 / 2127
(99%)
P. aeruginosa RP73
853 / 855
(99%)
1297 / 1302
(99%)
786 / 792
(99%)
2118 / 2127
(99%)
P. aeruginosa PA96
854 / 855
(99%)
1299 / 1302 
(99%)
785 / 792 
(99%)
2115 / 2127
(99%)
P. aeruginosa UCBPP-PA14
846 / 854 
(99%)
1286 / 1302 
(99%)
783 / 792 
(99%)
2108 / 2127
(99%)
P. aeruginosa PA7
788 / 855
(92%)
1188 / 1302 
(91%)
757 / 792
(96%)
2001 / 2127 
(94%)
P. protegens Cab57
1436 / 2007 
(72%)
P. stutzeri A1501
1465 / 2062 
(71%)
P. mendocina ymp
1478 / 2094 
(71%)
P. mandelii JR-1
1432 / 2017 
(71%)
Burkholderia sp. 383
577 / 828
(70%)
Serratia sp. FS14
530 / 782
(68%)
255 / 373
(68%)
Serratia marcescens WW4
514 / 759
(68%)
Arsenophonus nasoniae
487 / 726
(67%)
Vibrio nigripulchritudo str. 
SFn1
250 / 385
(65%)
Actinosynnema mirum DSM 
43827
207 / 285
(73%)
Bordetella bronchiseptica 
253
38 / 43 
(88%)
Bordetella bronchiseptica 
MO149
38 / 43
(88%)
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Azotobacter vinelandii CA6
1480 / 2023 
(73%)
Azotobacter vinelandii CA
1480 / 2023 
(73%)
The ΔPA4834 mutant grew completely fine in LB unlike AMS. And in our result 
of antibiotic sensitivity assay, the mutant exhibited an equal sensitivity to antibiotics 
with its parental strain PAO1 (Table 6). ΔPA4834 mutant had no change in fitness or 
stability as a consequence of gene manipulation. The responses of PA4834 to AMS 
are due to the functional defect in the PA4834 gene.
Table 6. Antibiotic susceptibility test
Antibiotics
Inhibition zone (mm)
PA01 ΔPA4834
Amikacin 24 26
Ceftazidime 27 29
Ciprofloxacin 34 33
Gentamicin 19 21
Tobramycin 26 26
Cefoperazone-sulbactam 27 27
Piperacillin 28 28
Imipenem 24 26
Piperacillin-tazobactam 29 30
Aztreonam 26 27
Meropenem 31 31
Cefepime 30 31
Colistin 13 13
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Figure 2. A PAO1 mutant devoid of the PA4834 gene lost its ability to grow in AMS. 
(A) Bacterial strains indicated at the top were grown in LB (white bars) and in AMS 
(gray bars), and the growth index for each strain was measured. Experimental 
conditions were identical to those described in Fig. 1A. Five independent experiments 
were performed, and mean values ± SD (error bars) are displayed in each bar. SA, S. 
aureus. *p < 0.05 vs. growth indices of PA4834::Tn, ΔPA4834, and ΔPA4834/pJN105. 
(B) Scanning electron microscope of primary cultured NHTE cells infected with 
PAO1, SA and ΔPA4834 mutant. Images are original magnification; 10,000× (C) 
Quantitative real-time PCR was performed to assess PA4834, PA4835, PA4836, and 
PA4837 gene transcript levels. PAO1 cells were grown in LB or AMS before RNA 
extraction. Transcript levels of the PA4834, PA4835, PA4836, and PA4837 genes in 
LB-grown PAO1 were normalized to 1.0, respectively. Three independent 
experiments were performed, and mean values ± SD are displayed in each bar.
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3. The PA4834 gene product is essential for iron acquisition during the interaction 
with AMS
Our microarray analysis indicated that genes involved in iron metabolism were 
highly transcribed in response to AMS treatment. Moreover, PA2033, annotated as a 
hypothetical gene, is predicted to encode a protein homologous to a siderophore-
interacting protein (www.pseudomonas.com). All of this information led us to 
hypothesize that PAO1 likely activates its response to acquire iron during treatment
with AMS, and PA4834 gene deficiency may result in the failure of such a process. In 
line with this notion, AMS was reported to contain large amounts of lactoferrin12,36
and transferrin,37 which can sequester free iron to restrict bacterial growth. 
When the ΔPA4834 mutant was grown in AMS supplemented with 100 μM ferric 
iron, its viability was completely recovered (Fig. 3A). The growth index of wild-type 
PAO1 was comparable in the presence or absence of added FeCl3. We then compared 
the relative sensitivity of PAO1 and the mutant under iron-depleted conditions. PAO1 
showed better resistance to the presence of increasing concentrations of 2,2’-bipyridyl, 
an iron chelator. At a 1.6 mM concentration, PAO1 grew significantly better than the 
ΔPA4834 mutant (Fig. 3B). ICP-MS analysis is a useful technique to measure total
iron concentration in bacterial cells.38 Intracellular iron concentration of the mutant 
was only slightly lower than PAO1, when strains were grown in LB (Fig. 3C). 
However, a dramatic difference was induced when the strains were grown in AMS. 
While a significantly increased level of intracellular iron was detected in AMS-grown 
PAO1, iron concentration in the ΔPA4834 mutant was considerably decreased under 
the same growth condition (Fig. 3C). This result suggests that PAO1 cells, but not the 
mutant cells, are capable of activating cellular machineries to uptake iron. Likewise, 
when bacterial cells were stained with PhenGreen™ SK, diacetate, a green-
fluorescent heavy metal indicator, a sharp increase in green fluorescent signal was 
detected in PAO1 grown in AMS vs. LB (Fig. 3D). Consistent with the ICP-MS 
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results, such an increase was not observed in the ΔPA4834 mutant, further 
demonstrating that the possession of intact PA4834 gene is crucial for adjusting
bacterial physiological status to an adverse environment, where iron limitation is 
involved. To compare the relative siderophore activities of bacterial species, iron 
sequestration assay was performed using SideroTech Kit (Fig. 3E). The result 
demonstrated that (i) PAO1 produced by far the largest amount of siderophore and (ii) 
all other species found to be susceptible to the AMS treatment (Fig. 1) produced 
significantly lower levels of siderophore. This new result further suggests that the 
resistant growth of P. aeruginosa in AMS is strongly related with its robust iron 
sequestration activity. Importantly, iron sequestration activity was ~2-fold decreased 
in the ΔPA4834 mutant, which was completely restored by PA4834 gene 
complementation.
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Figure 3. The PA4834 gene product plays a role in iron acquisition. (A) Effect of 
ferric iron on growth of the ΔPA4834 mutant in AMS. Growth indices of PAO1 and 
the ΔPA4834 mutant after growth in LB (white bars) or in AMS (grays bars) in the 
absence or presence of 100 μM FeCl3. Experimental conditions were identical to 
those described in Fig. 1A. Six independent experiments were performed, and mean 
values ± SD (error bars) are displayed in each bar. *p < 0.05 vs. growth of the 
ΔPA4834 mutant in AMS without extraneously added FeCl3. (B) Effect of an iron 
chelator on the growth of PAO1 and the ΔPA4834 mutant. Growth indices of PAO1 
(white bars) and the ΔPA4834 mutant (gray bars) were calculated after growth in LB 
supplemented with increasing concentrations of 2, 2’-bipyridyl. Bacterial cells were 
grown for 12 hrs. Four independent experiments were performed, and mean values ± 
SD (error bars) are displayed in each bar. *p < 0.05 vs. growth of PAO1 in the same 
media. (C) Intracellular iron concentration of PAO1 (white bars) and the ΔPA4834
mutant (gray bars) after growth in LB or in AMS. Inductively coupled plasma mass 
spectrometry (ICP-MS) was used for the measurement and iron concentrations are 
displayed in parts per billion (ppb). (D) Fluorescent microscope images of PAO1 and 
the ΔPA4834 mutant. After growth in LB or AMS, bacterial suspensions were stained 
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with PhenGreen™ SK, diacetate, a green fluorescent heavy metal indicator. 
Experiments were repeated three times and representative images, processed at the 
same magnification, are shown. (E) Bacterial strains indicated at the bottom were 
grown in LB for 16 hrs and cell-free culture supernatants were subject to the iron 
sequestration assay. The iron sequestration activities of indicated species were 
normalized with that of PAO1.
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4. Pyochelin and pyoverdine are dispensable for maintaining viability during
incubation with AMS
Our results demonstrate that expression of PA4834 is substantially stimulated 
upon exposure to AMS, which likely encodes a protein critical for iron acquisition. In 
P. aeruginosa, two major siderophore molecules, pyochelin and pyoverdine, have
been extensively studied to determine their roles in iron metabolism.15,39,40 As was 
shown in our microarray results, expression of genes involved in the production of 
these two molecules was also upregulated in response to treatment with AMS. We 
therefore sought to examine the relative importance of each system in terms of
responsiveness to AMS. To address this issue, we constructed a series of mutants and 
calculated the growth index of each mutant. P. aeruginosa single mutants deficient in 
the production of either pyochelin or pyoverdine were completely viable in response 
to AMS treatment (Fig. 4A). Importantly, a ΔpvdΔpch double mutant defective in both 
pyochelin and pyoverdine also remained viable in response to the same treatment. Of 
note, the growth indices of the Δpvd, Δpch, or ΔpvdΔpch mutants were almost 
identical to that of PAO1, suggesting that the ability to produce these two 
siderophores is not required for the protective response to AMS. In contrast, when the 
PA4834 gene was additionally disrupted, all the mutants (ΔpchΔPA4834,
ΔpvdΔPA4834 and ΔpvdΔpchΔPA4834) were susceptible to the antimicrobial action 
of AMS (Fig. 4A). 
We next examined whether the susceptible ΔPA4834 mutant could be rescued 
from AMS treatment by supplementation with bacterial culture supernatants. As 
shown in Fig. 4B, when the ΔPA4834 mutant was grown in AMS amended with cell-
free culture supernatants from the ΔpvdΔpch mutant, its growth index was 
significantly increased. Culture supernatant of the triple mutant, however, failed to 
rescue the ΔPA4834 mutant (Fig. 4B) and the growth index was quite similar to that 
of the mutant grown in AMS. This result further demonstrates that secretory 
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molecule(s), the production of which is dependent on the presence of the PA4834 gene
product, is critically necessary for the survival and proliferation of P. aeruginosa in 
AMS. 
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Figure 4. Growth of PAO1 pyochelin and pyoverdine mutants in AMS. (A) Bacterial 
strains (indicated by numbers) were grown in LB (white bars) or AMS (gray bars) for 
16 hrs and the growth index of each strain was measured. Experimental conditions 
were identical to those described in Fig. 1A. Three independent experiments were 
performed, and mean values ± SD (error bars) are displayed in each bar. (B) Effect of 
bacterial culture supernatant (CS) on ΔPA4834 mutant growth in AMS. The ΔPA4834 
mutant was grown in LB (white bar) and AMS supplemented with the CS from the 
ΔpvdΔpch double or ΔPA4834ΔpvdΔpch triple mutant (gray bars). CSs were obtained 
from bacterial cultures grown in LB and diluted 10-fold in AMS. *p < 0.05 vs. growth 
of the ΔPA4834 mutant in AMS or AMS amended with the CS from the ΔPA4834 
ΔpvdΔpch mutant.
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5. Supplementation of nicotianamine (NA) restores ability of the ΔPA4834 mutant to 
grow in AMS
The PA4836 gene encodes a putative NA synthase. NA is a compound with high-
affinity for iron and it has been extensively studied in plants.41,42 Furthermore, the 
PA4837 gene product likely acts as a siderophore receptor suggesting the involvement 
of this genetic element in iron acquisition. This information led us to postulate that P. 
aeruginosa may also produce NA to sustain its growth in AMS. To address this issue, 
we examined whether NA supplementation could rescue growth of the ΔPA4834 
mutant in AMS. Similar to previous results, PAO1 was capable of growing in AMS 
regardless of the presence of 100 μM NA (Fig. 5). Importantly, growth of the 
ΔPA4834 mutant was completely restored by the presence of 100 μM NA (Fig. 5). 
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Figure 5. Effect of the addition of nicotianamine (NA) on ΔPA4834 mutant growth in 
AMS. PAO1 and the ΔPA4834 mutant were grown in AMS (white bars) and AMS 
amended with 100 μM NA (gray bars) and growth indices were measured. 
Experimental conditions were identical to those described in Fig. 1A. Five 
independent experiments were performed, and mean values ± SD (error bars) are 
displayed in each bar. *p < 0.05 vs. growth of the ΔPA4834 mutant in AMS with no 
NA supplementation.
32
6. In vivo virulence of the ΔPA4834 mutant is attenuated
We next examined whether in vivo infectivity of PAO1 was affected by deletion 
of the PA4834 gene by employing the burn wound infection and airway infection
mouse models. In both cases, infectivity of the ΔPA4834 mutant was significantly 
compromised. The average number of viable cells recovered from the infected burn 
wound areas indicated that the mutant was less capable of proliferating than its 
parental strain PAO1 (Fig. 6A). Furthermore, while severe inflammation was clearly 
induced by infection with PAO1, the degree of inflammation was considerably 
decreased by infection with the same dose of the ΔPA4834 mutant (Fig. 6B). The 
attenuation of bacterial virulence by the PA4834 gene deletion was even more 
dramatic in the acute mouse lung infection model. The average number of viable cells 
enumerated from the infected lung of PAO1-infected mice was ~1.8×108/ml, while it 
was decreased to ~1.4×106/ml in mice initially infected with the same number of 
mutant cells (Fig. 6C), clearly suggesting that the mutant was not competent in 
establishing airway infection. As expected, a high degree of inflammation was only
induced in the lung tissues of mice infected with PAO1, but not with the ΔPA4834 
mutant (Fig. 6D).                                     
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Figure 6. In vivo infectivity of the ΔPA4834 mutant is decreased. (A, B) Mouse burn 
wound infection. (A) PAO1 and the ΔPA4834 mutant were infected in the thermally-
injured region of the mouse skin. The infection dose was 2×108 bacterial cells. After 
24 hrs, the infected area was incised and homogenized to enumerate viable cells. Four
independent experiments were performed, and mean values ± SD (error bars) are 
displayed in each bar. *p < 0.05 vs. CFU of PAO1. ND, not detected. (B) Histological 
images of infected skin sections of mice challenged with PBS (negative control), 
PAO1, or the ΔPA4834 mutant. (C, D) Mouse airway infection. (C) PAO1 and the 
ΔPA4834 mutant (1×107 CFU) were exposed to the mouse airway via the intranasal 
route. After 24 hrs, mouse lungs were removed and homogenized to enumerate viable 
cells. Four independent experiments were performed, and mean values ± SD (error 
bars) are displayed in each bar. *p < 0.05 vs. CFU of PAO1. ND, not detected. (D) 
Representative histological images of lung sections of mice challenged with PBS
(negative control), PAO1, or the ΔPA4834 mutant.
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Ⅳ. DISCUSSION
Airway mucus is a key component of the innate immunity that mediates the 
elimination of inhaled microorganisms via mucociliary clearance.33,43,44 It contains 
antimicrobial components such as lysozymes and defensing.45 The bactericidal 
activity, however, is compromised in the diseased CF airway due to the abnormally 
altered mucus environment and P. aeruginosa is capable of establishing recalcitrant 
infection under such conditions.4,9,46 Given the fact that the CF patient airway is 
equally exposed to various opportunistic pathogens, it remains a question as to why P. 
aeruginosa has been so successful in colonizing and proliferating in the CF patient 
airway.11,47,48 Here, we addressed this long-standing question using ex vivo AMS 
experimental conditions to study the host-microbe interaction, mimicking the early 
stages of airway infection. P. aeruginosa was capable of propagating upon interaction 
with AMS, a finding not observed in other tested bacterial species. These data 
strongly suggest that P. aeruginosa infection in patients with CF, COPD, or ventilator 
care stems from the specific response of P. aeruginosa to the airway environment and 
not from the abnormal composition of the airway mucus per se. This notion was 
further verified by our findings that P. aeruginosa was equally capable of propagating 
in secretions of cultured epithelial cells derived from a CF patient (CuFi-1) or a 
normal individual (NuLi-1). The growth of P. aeruginosa in nasal secretions collected 
from healthy volunteers has been previously reported,49 since then, it has been further 
elucidated that airway mucus provides the carbon source P. aeruginosa needs to 
proliferate.47,50
We then explored mechanisms by which P. aeruginosa is resistant to airway 
mucus, which is a completely different response than what is seen in other bacterial 
species. We focused on the PAO1 genes upregulated when exposed to AMS. Our 
microarray data showed that various genes related to iron uptake and metabolism 
were upregulated when P. aeruginosa is exposed to AMS. In particular, genes that 
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encode proteins involved in the production of siderophores such as pyoverdine and 
pyochelin were substantially upregulated, which is remarkably similar to previous 
studies where P. aeruginosa was exposed to airway mucus and low iron 
environments.51-53 P. aeruginosa is known to have a special ability to utilize small 
amounts of iron by the synthesis of siderophores such as pyoverdine and 
pyochelin.15,54-56 We also confirmed that PAO1 has higher siderophore activity than 
other bacteria. Based on these findings, we assumed that the selective resistance of P. 
aeruginosa to airway mucus came from the ability of P. aeruginosa to survive in low 
iron concentration conditions via a special iron-utilizing system.
To test this assumption, we screened for the critical gene(s) necessary for the 
survival of P. aeruginosa in airway mucus using transposon insertion mutants with 
special attention to genes regulating iron metabolism. In contrast to our expectations, 
transposon mutants defective in the production of pyoverdine and pyochelin, 
chemicals known to be important for iron acquisition, were able to survive upon 
treatment with AMS, while the PA4834 mutant lost its resistance to airway mucus. 
The PA4834 gene encodes a membrane-associated protein (284 amino acids) that 
contains a duplication of the evolutionarily conserved EamA domain, a well-
characterized motif present in proteins belonging to the Drug and Metabolite 
Transporter (DMT) family. Of note, PA4834 has a 51% amino acid similarity to the S-
adenosylmethionine (SAM) uptake transporter of Paracoccus aminophilus strain JCM 
7686. In addition, SAM is a precursor of NA, a well-characterized phytosiderophore 
produced by plants.57,58 The PA4834 gene is part of a putative operon with the PA4835, 
PA4936 and PA4837 genes, and a BLASTN search demonstrated that this particular 
gene cluster is exclusively present in P. aeruginosa strains. The PA4837 gene is 
predicted to encode a TonB-dependent siderophore receptor. The PA4836 gene, 
although annotated as a hypothetical protein in the PAO1 genome database, likely 
encodes a protein homologous to NA synthase. Therefore, it was reasonable to 
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hypothesize that this operon is related to a new iron transport system and the 
possession of this system may account for the resistance of P. aeruginosa to airway
mucus. Although the primary sequence of the PA4834 protein is similar to the SAM 
uptake transporter, the possibility of PA4834 acting as a SAM transporter is low 
because the concentration of intracellular SAM was comparable in both the PAO1 and 
ΔPA4834 mutant (data not shown). Importantly, the ability of the ΔPA4834 mutant to 
grow in AMS was recovered by the extraneous addition of NA. Thus, it is highly 
possible that PA4834 encodes a protein involved in NA secretion. Consistent with our 
finding, previous genome-wide studies also reported the potential importance of this 
genetic region for the survival of P. aeruginosa in the airway environment. First, the 
PA4834-PA4837 operon has been shown to be upregulated in P. aeruginosa strain 
PA14 growing on artificial sputum medium as a sole carbon source.47 Second, the 
PA4837 gene was found to be expressed in P. aeruginosa clinical CF isolates early in 
CF infection.59 Third, expression of genes in this operon was also markedly increased 
when P. aeruginosa strain PA14 was grown in the peritoneal cavity of a rat.60 Lastly, 
the PA4935 and PA4836 genes were exclusively expressed under in in vivo burn 
wound infections.61 These findings, together with our results, strongly suggest that the 
PA4834-PA4837 operon plays an essential role in bacterial proliferation in airway 
mucus. Under iron-replete conditions like LB media, both PAO1 and the ΔPA4834
mutant may sequester iron with siderophores such as pyochelin and pyoverdine. 
However, our results demonstrate that bacterial growth of the PAO1 mutant defective 
in production of these two molecules alone was not affected during incubation with 
AMS, while the PA4834 gene mutation resulted in a significant defect in bacterial 
ability to cope with AMS-induced stress. 
Although this study identified a new genetic element that accounts for the 
exceptional ability of P. aeruginosa to propagate in human airway mucus, our study 
does have the following limitations. First, because AMS samples were only provided 
37
in small quantities, we were only able to grow P. aeruginosa strains for a short period 
of time. Considering that P. aeruginosa establishes chronic biofilm infection in the CF 
airway,44 our experiments using AMS may not be completely relevant to describe P. 
aeruginosa pathogenesis in vivo. Second, because AMS samples were prepared from 
outpatients with varying degrees of health conditions, differential antimicrobial 
activities were observed among the AMS preparations. Regardless, PAO1 cells were 
always resistant to AMS treatment while the ΔPA4834 mutant exhibited susceptibility 
to the same treatment. These difficulties could be overcome by constructing a stable 
airway cell line that secretes mucus with predictable composition. Lastly, deletion of 
the PA4834 gene resulted in a dramatic phenotype in response to AMS incubation and
the sole addition of NA completely rescued the ability of the ΔPA4834 mutant to grow 
in AMS. However, more experiments are necessary to precisely understand the 
molecular basis of how NA is produced, secreted, and internalized to act as a 
siderophore and how each gene product of the operon contributes to this process.
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Ⅴ. CONCLUSION
In conclusion, our data show that P. aeruginosa can selectively grow in airway 
mucus by utilizing a newly identified iron uptake system. Our present results provide 
fundamental insight into the competent behavior of P. aeruginosa under airway-
specific environments. Selective growth of P. aeruginosa in the CF airway is caused 
by the ability of this important pathogen to manage adverse mucus conditions, such as 
low iron availability, and not due to the compositional changes of the airway mucus
per se. Therefore, any condition where the mucociliary clearance system is impaired 
in patients with CF, COPD, or prolonged ventilator use can lead to P. aeruginosa
infection. Our findings also suggest that the suppression of PA4834 gene expression
or blocking the biological activity of the PA4834 gene product can be novel 
approaches to the treatment of P. aeruginosa infections.  
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ABSTRACT (IN KOREAN)
기도점액에서 녹농균이 생장하는데 필수적인 역할을 하는
새로운 철분포획체 시스템
<지도교수 최 재 영>
연세대학교 대학원 의과학과
기 미 아
녹농균은 낭포성 섬유증 환자에서 호흡기 감염을 일으키는 균으로
치명적이다. 본 논문에서는 초대 배양된 정상 사람의 기도 상피
세포로부터 분비되는 기도점액 분비물과 녹농균의 상호작용에 대하여
연구하기 위하여 기도점액 분비물에서 여러 균들을 배양해 보았다. 실험
결과 균들은 기도점액 분비물에서 살아남지 못했다. 하지만 녹농균의
원형인 PAO1은 기도점액 분비물에서 생존 할 뿐만 아니라 증식하였다. 
이러한 결과에 영향을 미치는 유전적 요소를 찾고자 마이크로어레이
기법을 이용하여 기도점액 분비물에 반응하여 증가하는 PAO1의 유전자를
분석하였다. 증가된 유전자가 각각 돌연변이 된 PAO1을 기도점액
분비물에서 배양하였다. 그 결과 PAO1의 PA4834 유전자가 조작된 ΔPA4834 
돌연변이체가 기도점액 분비물에서 다른 균들처럼 생존하지 못하였다. 이
ΔPA4834 돌연변이체는 100 μM의 고농도의 제 2철을 첨가하였을 때
재생장 하였다. 또한 기도점액 분비물에서 배양한 후 세포 내 철의 양을
측정해 보았을 때 PAO1과 비교하여 ΔPA4834 돌연변이체의 세포 내 철의
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양이 현저히 감소되어 있었다. 이러한 결과들은 PA4834 유전자가 철
획득을 위해 중요한 역할을 할 것이라는 것을 보여준다. 녹농균은 기능이
잘 알려진 철분포획체인 pyoverdine과 pyochelin을 철 획득을 위하여 주로
이용한다. 하지만 이 두 철분포획체를 분비하지 못하도록 조작된 PAO1의
돌연변이체는 기도점액 분비물에서 생장하였다. PA4834 유전자와 같이
조절되는 오페론의 유전자 중 PA4836 유전자는 식물의 철분포획체인
nicotianamine을 합성하는데 관여할 것으로 여겨지고 있다. 본 연구에서, 
nicotianamine (100 μM)을 기도점액 분비물에 첨가하였을 때 ΔPA4834
돌연변이체가 재생장 하는 것을 확인하였다. 이러한 결과들은 PA4834
유전자가 새로운 철분포획체 시스템의 일원으로 기도점액 분비물에서
PAO1이 선택적으로 증식하는데 있어 중요한 요소임을 보여준다. 또한
ΔPA4834 돌연변이체에 의한 in vivo 감염성은 PAO1과 비교하여
감소한다는 것을 확인하였다. 종합하면, 본 논문은 기존에 밝혀지지 않은
새로운 철 획득 시스템을 코딩하는 녹농균의 유전인자를 밝혔고 이는
호흡기 감염에 일차적인 방어체계인 기도점액에서 녹농균이 생존하는데
중요한 요소임을 보여주고 있다.
핵심되는 말: PA4834 유전자, 철분포획체, 기도점액 분비물
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